Therapeutic Drug Monitoring of Beta-Lactams and Other Antibiotics in the Intensive Care Unit: Which Agents, Which Patients and Which Infections?
- PMID: 29476349
- DOI: 10.1007/s40265-018-0880-z
Therapeutic Drug Monitoring of Beta-Lactams and Other Antibiotics in the Intensive Care Unit: Which Agents, Which Patients and Which Infections?
Abstract
Antibiotics are among the medications most frequently administered to the critically ill, a population with high levels of intra- and inter-individual pharmacokinetic variability. Our knowledge of the relationships among antibiotic dosing, exposure and clinical effect in this population has increased in recent decades. Therapeutic drug monitoring (TDM) of serum antibiotic concentrations is the most practical means of assessing adequate antibiotic exposure, though until recently, it has been underutilised for this end. Now TDM is becoming more widespread, particularly for the beta-lactam antibiotics, a class historically thought to have a wide therapeutic range. We review the basic requirements, indications, and targets for effective TDM of the glycopeptides, aminoglycosides, quinolones and beta-lactam antibiotics in the adult intensive-care setting, with a special focus on TDM of the beta-lactam antibiotics, the most widely used antibiotic class.
Similar articles
-
Impact of β-lactam antibiotic therapeutic drug monitoring on dose adjustments in critically ill patients undergoing continuous renal replacement therapy.Int J Antimicrob Agents. 2017 May;49(5):589-594. doi: 10.1016/j.ijantimicag.2017.01.009. Epub 2017 Mar 21. Int J Antimicrob Agents. 2017. PMID: 28341612
-
Therapeutic drug monitoring of β-lactam antibiotics in the ICU.Expert Rev Anti Infect Ther. 2020 Nov;18(11):1155-1164. doi: 10.1080/14787210.2020.1788387. Epub 2020 Jul 5. Expert Rev Anti Infect Ther. 2020. PMID: 32597263 Review.
-
An international, multicentre survey of β-lactam antibiotic therapeutic drug monitoring practice in intensive care units.J Antimicrob Chemother. 2014 May;69(5):1416-23. doi: 10.1093/jac/dkt523. Epub 2014 Jan 16. J Antimicrob Chemother. 2014. PMID: 24443514
-
The effect of therapeutic drug monitoring of beta-lactam and fluoroquinolones on clinical outcome in critically ill patients: the DOLPHIN trial protocol of a multi-centre randomised controlled trial.BMC Infect Dis. 2020 Jan 17;20(1):57. doi: 10.1186/s12879-020-4781-x. BMC Infect Dis. 2020. PMID: 31952493 Free PMC article. Clinical Trial.
-
Ensuring target concentrations of antibiotics in critically ill patients through dose adjustment.Expert Opin Drug Metab Toxicol. 2022 Mar;18(3):177-187. doi: 10.1080/17425255.2022.2056012. Epub 2022 Mar 28. Expert Opin Drug Metab Toxicol. 2022. PMID: 35311440 Review.
Cited by
-
Stratified Management for Bacterial Infections in Late Preterm and Term Neonates: Current Strategies and Future Opportunities Toward Precision Medicine.Front Pediatr. 2021 Apr 1;9:590969. doi: 10.3389/fped.2021.590969. eCollection 2021. Front Pediatr. 2021. PMID: 33869108 Free PMC article. Review.
-
Some Suggestions from PK/PD Principles to Contain Resistance in the Clinical Setting-Focus on ICU Patients and Gram-Negative Strains.Antibiotics (Basel). 2020 Oct 6;9(10):676. doi: 10.3390/antibiotics9100676. Antibiotics (Basel). 2020. PMID: 33036190 Free PMC article. Review.
-
Usefulness of therapeutic drug monitoring of piperacillin and meropenem in routine clinical practice: a prospective cohort study in critically ill patients.Eur J Hosp Pharm. 2020 Mar;27(e1):e30-e35. doi: 10.1136/ejhpharm-2018-001713. Epub 2019 Feb 27. Eur J Hosp Pharm. 2020. PMID: 32296502 Free PMC article.
-
Evaluation of a Meropenem and Piperacillin Monitoring Program in Intensive Care Unit Patients Calls for the Regular Assessment of Empirical Targets and Easy-to-Use Dosing Decision Tools.Antibiotics (Basel). 2022 Jun 2;11(6):758. doi: 10.3390/antibiotics11060758. Antibiotics (Basel). 2022. PMID: 35740164 Free PMC article.
-
Barriers and facilitators for therapeutic drug monitoring of beta-lactams and ciprofloxacin in the ICU: a nationwide cross-sectional study.BMC Infect Dis. 2022 Jul 13;22(1):611. doi: 10.1186/s12879-022-07587-w. BMC Infect Dis. 2022. PMID: 35831793 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical